Related Experiment Video
Updated: Feb 22, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Mapping the Heterogeneity of Mortality: Age- and Race-Specific Trajectories in 839,698 Breast Cancer Survivors
Zheng Li1, Shengbin Pei1, Zheng Qu1,2
1Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Background:
With steadily rising survival rates, the cause-of-death landscape for breast cancer patients is evolving. This study.
Aims:
to delineate mortality patterns and demographic disparities to inform long-term survivorship strategies.
Methods:
We performed a retrospective analysis of 839,698 breast cancer patients from U.S. population-based registries (2000-2021). Standardized Mortality Ratios (SMRs) and Incidence Rate Ratios (IRRs) were calculated to assess the risk of non-cancer deaths across age and racial/ethnic groups.
Results:
By 10 years of follow-up, 48.6% of all deaths were attributed to non-cancer causes. Significant disparities emerged: Black patients (aged 0-54) exhibited the highest all-cause mortality risk (IRR: 1.70; 95% CI: 1.66-1.74), whereas Asian/Pacific Islanders (aged 65-74) showed the lowest (IRR: 0.67; 95% CI: 0.65-0.69). Notably, patients faced drastically elevated risks for external causes, including suicide (SMR: 17.4; 95% CI: 16.1-18.8) and homicide (SMR: 10.1; 95% CI: 8.37-12.13), alongside cardiovascular/non-cancer diseases.
Conclusion:
Mortality in breast cancer survivors is progressively shifting from malignancy to non-cancer causes, with distinct racial and age-dependent patterns. These findings necessitate a paradigm shift toward personalized, risk-stratified survivorship care that integrates cardiovascular monitoring and psychosocial interventions.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Longitudinal Research
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Kaplan-Meier Approach
Assumptions of Survival Analysis

